50 related articles for article (PubMed ID: 16544283)
1. Differential proteome profiles in E2F2-deficient T lymphocytes.
Azkargorta M; Arizmendi JM; Elortza F; Alkorta N; Zubiaga AM; Fullaondo A
Proteomics; 2006 Apr; 6 Suppl 1():S42-50. PubMed ID: 16544283
[TBL] [Abstract][Full Text] [Related]
2. Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice.
Iglesias A; Murga M; Laresgoiti U; Skoudy A; Bernales I; Fullaondo A; Moreno B; Lloreta J; Field SJ; Real FX; Zubiaga AM
J Clin Invest; 2004 May; 113(10):1398-407. PubMed ID: 15146237
[TBL] [Abstract][Full Text] [Related]
3. The combined effect of BCL-2 over-expression and E2F2 deficiency induces an autoimmune syndrome in non-susceptible mouse strain C57BL/6.
Marín-Vidalled MJ; Bolívar A; Zubiaga A; López-Hoyos M
Autoimmunity; 2010 Mar; 43(2):111-20. PubMed ID: 20187704
[TBL] [Abstract][Full Text] [Related]
4. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity.
Murga M; Fernández-Capetillo O; Field SJ; Moreno B; Borlado LR; Fujiwara Y; Balomenos D; Vicario A; Carrera AC; Orkin SH; Greenberg ME; Zubiaga AM
Immunity; 2001 Dec; 15(6):959-70. PubMed ID: 11754817
[TBL] [Abstract][Full Text] [Related]
5. A role for transcription factor E2F2 in hepatocyte proliferation and timely liver regeneration.
Delgado I; Fresnedo O; Iglesias A; Rueda Y; Syn WK; Zubiaga AM; Ochoa B
Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G20-31. PubMed ID: 21527726
[TBL] [Abstract][Full Text] [Related]
6. E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivo.
Ebelt H; Zhang Y; Kampke A; Xu J; Schlitt A; Buerke M; Müller-Werdan U; Werdan K; Braun T
Cardiovasc Res; 2008 Nov; 80(2):219-26. PubMed ID: 18628254
[TBL] [Abstract][Full Text] [Related]
7. Experimental autoimmune encephalomyelitis develops in CC chemokine receptor 7-deficient mice with altered T-cell responses.
Pahuja A; Maki RA; Hevezi PA; Chen A; Verge GM; Lechner SM; Roth RB; Zlotnik A; Alleva DG
Scand J Immunol; 2006 Oct; 64(4):361-9. PubMed ID: 16970675
[TBL] [Abstract][Full Text] [Related]
8. Proteomic profile of mouse fibroblasts with a targeted disruption of the peroxisome proliferator activated receptor-beta/delta gene.
Adamkiewicz J; Kaddatz K; Rieck M; Wilke B; Müller-Brüsselbach S; Müller R
Proteomics; 2007 Apr; 7(8):1208-16. PubMed ID: 17380536
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
10. Differential proteomics analysis reveals a role for E2F2 in the regulation of the Ahr pathway in T lymphocytes.
Azkargorta M; Fullaondo A; Laresgoiti U; Aloria K; Infante A; Arizmendi JM; Zubiaga AM
Mol Cell Proteomics; 2010 Oct; 9(10):2184-94. PubMed ID: 20573986
[TBL] [Abstract][Full Text] [Related]
11. A differentially expressed proteomic analysis in placental tissues in relation to pungency during the pepper fruit development.
Lee JM; Kim S; Lee JY; Yoo EY; Cho MC; Cho MR; Kim BD; Bahk YY
Proteomics; 2006 Oct; 6(19):5248-59. PubMed ID: 16947123
[TBL] [Abstract][Full Text] [Related]
12. A chimeric TCR-beta chain confers increased susceptibility to EAE.
Petersen TR; Lata R; Spittle E; Bäckström BT
Mol Immunol; 2007 Jul; 44(14):3473-81. PubMed ID: 17481734
[TBL] [Abstract][Full Text] [Related]
13. A role for STAT5A/B in protection of peripheral T-lymphocytes from postactivation apoptosis: insights from gene expression profiling.
Gatzka M; Piekorz R; Moriggl R; Rawlings J; Ihle JN
Cytokine; 2006 May; 34(3-4):143-54. PubMed ID: 16757175
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the proteomic changes of the serum of the Smad3 targeted deficient mice].
Hao ZM; Yang X; Ying WT; Wang J; Qian XH; Huang CF
Sheng Wu Gong Cheng Xue Bao; 2002 Jul; 18(4):452-6. PubMed ID: 12385242
[TBL] [Abstract][Full Text] [Related]
15. Comparative proteome analysis of three mouse lung adenocarcinoma CMT cell lines with different metastatic potential by two-dimensional gel electrophoresis and mass spectrometry.
Zhang K; Wrzesinski K; Stephen JF; Larsen PM; Zhang X; Roepstorff P
Proteomics; 2008 Dec; 8(23-24):4932-45. PubMed ID: 19003861
[TBL] [Abstract][Full Text] [Related]
16. The E2F2 transcription factor sustains hepatic glycerophospholipid homeostasis in mice.
Maldonado EN; Delgado I; Furland NE; Buqué X; Iglesias A; Aveldaño MI; Zubiaga A; Fresnedo O; Ochoa B
PLoS One; 2014; 9(11):e112620. PubMed ID: 25396754
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel Stat6 regulated proteins in IL-4-treated mouse lymphocytes.
Tuomela S; Rautajoki KJ; Moulder R; Nyman TA; Lahesmaa R
Proteomics; 2009 Feb; 9(4):1087-98. PubMed ID: 19180534
[TBL] [Abstract][Full Text] [Related]
18. Comparative proteome analysis of splenic lymphocytes in senescence-accelerated mice.
Luo Y; Li Y; Lin C; Ma H; Zhang J; Wu S; Wang X; Gao Y; Liu Y; Zheng D
Gerontology; 2009; 55(5):559-69. PubMed ID: 19546514
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of the E2F1 response in p53-negative cancer cells: new aspects in the regulation of cell survival and death.
Li Z; Kreutzer M; Mikkat S; Mise N; Glocker MO; Pützer BM
Proteomics; 2006 Nov; 6(21):5735-45. PubMed ID: 17001603
[TBL] [Abstract][Full Text] [Related]
20. Dok-1 and Dok-2 are negative regulators of T cell receptor signaling.
Yasuda T; Bundo K; Hino A; Honda K; Inoue A; Shirakata M; Osawa M; Tamura T; Nariuchi H; Oda H; Yamamoto T; Yamanashi Y
Int Immunol; 2007 Apr; 19(4):487-95. PubMed ID: 17329234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
